Overview of Рабепразол-СЗ
What is Рабепразол-СЗ? (Rabeprazole-SZ)
The section below provides an overview of Рабепразол-СЗ, focusing strictly on its identity, composition, class, and general purpose.
| Property | Description |
|---|---|
| Active ingredient | Rabeprazole sodium |
| Form | Delayed-release tablets (enteric-coated) |
| Pharmacological class | Proton Pump Inhibitor (PPI) |
| Common purpose | Sustained gastric acid suppression |
| Origin | Synthetic, substituted benzimidazole |
Definition, Active Ingredient, and Pharmacological Class
Рабепразол-СЗ is a synthetic, single-ingredient medication classified pharmacologically as a Proton Pump Inhibitor (PPI). Its active component is Rabeprazole sodium, which is a derivative of the substituted benzimidazole chemical class. Rabeprazole is utilized for its acid-suppressing capability.
Unlike antacids, which only neutralize existing acid, PPIs are designed to interfere directly with the final stage of acid production. Rabeprazole is also considered a prodrug, meaning it remains pharmacologically inactive until it is converted into its active form within the specific acidic environment of the stomach’s acid-producing cells, ensuring a targeted effect.
Composition and Specialized Dosage Form
The drug is prepared for oral use primarily as delayed-release (enteric-coated) tablets or capsules. This specialized pharmaceutical form is essential because Rabeprazole sodium is highly sensitive to acid and would be rapidly destroyed by gastric acid if administered without protection.
This acid-resistant coating ensures the active ingredient remains intact as it passes through the stomach and only releases the Rabeprazole into the less acidic environment of the small intestine for absorption. This strategic formulation helps ensure the drug maintains its chemical integrity and bioavailability, which is crucial for its effectiveness in cases requiring consistent acid control.
General Purpose: Sustained Gastric Acid Suppression
The general purpose of Рабепразол-СЗ is to achieve robust, sustained gastric acid suppression. The medicine functions by permanently blocking the proton pump (H^+/K^+-ATPase) in the stomach lining, the mechanism responsible for the final output of acid.
By inhibiting this pump, the medicine reduces the total acidity in the digestive tract. The primary benefit of this action is creating an environment conducive to the natural healing of the esophageal and stomach lining, which may be damaged by excessive acid production.
Regulatory References

